Marc Semigran

Marc J.
Semigran currently works at Broadview Ventures, Inc., as Advisor and Harvard Medical School, as Associate Professor from 2010.
Dr. Semigran also formerly worked at The General Hospital Corp., as Medical Director-Heart Failure from 2004 to 2016, The General Hospital Corp., as Medical Director from 2004 to 2006, Social Capital Suvretta Holdings Corp.
III, as Independent Director, MyoKardia, Inc., as Senior Vice President-Medical Sciences from 2019 to 2021, Renovacor Holdings, Inc., as Chief Medical Officer in 2021, Renovacor, Inc., as Chief Medical Officer, and Edgewise Therapeutics, Inc., as Chief Development Officer from 2022 to 2025.
Dr. Semigran received his graduate degree from Harvard University, undergraduate degree in 1978 from Harvard University, and doctorate degree in 1983 from Harvard Medical School.